Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29740319 | 1.00 | CYP19A1 (0.44) | CYP19A1CHRNB2CHRNA4NPC1RAB9A | |
| SCHEMBL16520501 | 0.89 | NPC1 (0.54) | CYP19A1CHRNB2CHRNA4NPC1RAB9A | |
| SCHEMBL30930597 | 0.87 | NPC1 (0.57) | CYP19A1NPC1RAB9ASMN1; SMN2NFKB1 | |
| SCHEMBL584462 | 0.87 | NPC1 (0.57) | CYP19A1NPC1RAB9ASMN1; SMN2NFKB1 | |
| SCHEMBL7280526 | 0.84 | CYP19A1 (0.58) | CYP19A1SMN1; SMN2PIK3CDMAPT | |
| SCHEMBL1000061 | 0.84 | CYP2A6 (0.48) | CYP19A1CHRNB2CHRNA4NPC1RAB9A | |
| SCHEMBL2824810 | 0.84 | PDGFRB (0.40) | CYP19A1NPC1RAB9ASMN1; SMN2NFKB1 | |
| SCHEMBL15901316 | 0.84 | METAP2 (0.38) | CYP19A1CHRNB2CHRNA4NPC1RAB9A | |
| SCHEMBL27814493 | 0.84 | MEN1 (0.58) | NPC1RAB9ASMN1; SMN2NFKB1NFKB2 | |
| SCHEMBL17157352 | 0.84 | LTA4H (0.48) | NPC1RAB9ASMN1; SMN2PIK3CDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025028487-A1 | MATERIAL FOR METAL PATTERNING, HETEROCYCLIC COMPOUND, THIN FILM FOR METAL PATTERNING, ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | 東ソー株式会社 | 2025-02-06 | — | — | WO | disclosed |
| US-20220185785-A1 | INHIBITORS OF CD40-CD154 BINDING | TONIX Pharmaceuticals Holding Corp (US) | 2022-06-16 | — | — | US | disclosed |
| EP-3952853-A1 | INHIBITORS OF CD40-CD154 BINDING | Tonix Pharmaceuticals Holding Corp. (US) | 2022-02-16 | — | — | EP | disclosed |
| WO-2020210831-A1 | INHIBITORS OF CD40-CD154 BINDING | TONIX Pharmaceuticals Holding Corp (US) | 2020-10-15 | — | — | WO | disclosed |
| WO-2020210831-A1 | INHIBITORS OF CD40-CD154 BINDING | TONIX Pharmaceuticals Holding Corp (US) | 2020-10-15 | — | — | WO | disclosed |
| EP-2616457-B1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORP (JP) | 2016-06-22 | — | — | EP | disclosed |
| EP-2616457-B1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORP (JP) | 2016-06-22 | — | — | EP | disclosed |
| US-9328086-B2 | Substituted bipyridines for use in organic light-emitting devices | NITTO DENKO CORPORATION (JP) | 2016-05-03 | — | — | US | disclosed |
| US-9328086-B2 | Substituted bipyridines for use in organic light-emitting devices | NITTO DENKO CORPORATION (JP) | 2016-05-03 | — | — | US | disclosed |
| US-9328086-B2 | Substituted bipyridines for use in organic light-emitting devices | NITTO DENKO CORPORATION (JP) | 2016-05-03 | — | — | US | disclosed |
| EP-2616457-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | Nitto Denko Corporation (JP) | 2013-07-24 | — | — | EP | disclosed |
| US-20120179089-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120179089-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120179089-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| WO-2012037269-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2012-03-22 | — | — | WO | disclosed |
| WO-2012037269-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2012-03-22 | — | — | WO | disclosed |
| US-20110123877-A1 | CATALYST FOR OXYGEN REDUCTION ELECTRODE AND OXYGEN REDUCTION ELECTRODE | NEC CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185785-A1 | INHIBITORS OF CD40-CD154 BINDING | CD40LG, CD40, CD4 | CYP19A1 2910/4885CHRNB2 2936/4885CHRNA4 844/4885 |
| US-20120179089-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | BRD9, PIR, BRD2 | CYP19A1 4488/4885CHRNB2 523/4885CHRNA4 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.